The Boehringer Ingelheim Foundation and the Board of Trustees will award the 2020 Heinrich Wieland Prize to

Professor Dr Craig M. Crews

Yale University, New Haven, CT, USA

for pioneering targeted protein degradation as a new principle in pharmacology.

Due to the COVID-19 pandemic, the personal presentation of our 2020 award and scientific symposium have been postponed until 2021. The Boehringer Ingelheim Foundation will honour the 2020 and 2021 Heinrich Wieland Prize laureates in a joint scientific sympoisum and festive award ceremony at Nymphenburg Palace in Munich on 21 October 2021. Details on the programme and how to participate in the event will be published in the summer.

In 2020, the Boehringer Ingelheim Foundation held a virtual event as part of Berlin Science Week for the first time, with Professor Craig M. Crews as the guest of honour. Besides introducing the Heinrich Wieland Prize in general and the 2020 laureate in particular, this event featured a discussion about how ideas spawned from curiosity-driven research can pave the way for new therapeutic approaches and enable the successful founding of science-based start-ups in the US and Germany. At the end of the event, the audience was invited to participate in a discussion and share their own experiences.

The event titled Starting up science: From lab to therapy took place on 2 November 2020. You can find more information about the virtual event held during Berlin Science Week here.

To learn more about Professor Craig M. Crews, please follow this link.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .